Researchers have newly identified a universal, essential biomarker for the childhood cancer neuroblastoma – and a potential new target for treatment.
Oslo biotech finds another merger partner after shareholders rejected November offer
Shareholders of Nordic Nanovector did not like the first merger partner the Norwegian biotech chose last fall. So the company went back to the drawing
June 9, 2023